ENOB RSI Chart
Last 7 days
20.3%
Last 30 days
14.7%
Last 90 days
-43.0%
Trailing 12 Months
-71.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2016 | 43.7K | 43.1K | 0 | 0 |
2015 | 0 | 0 | 0 | 43.7K |
2013 | 55.3K | 47.8K | 40.3K | 32.8K |
2012 | 0 | 0 | 0 | 62.8K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 26, 2023 | sindlev rene | acquired | 1,000,000 | 0.53 | 1,886,790 | - |
Mar 17, 2023 | sindlev rene | acquired | 1,000,000 | 1.14 | 877,193 | - |
Oct 13, 2022 | weird science llc | acquired | - | - | 1,216,470 | - |
Oct 13, 2022 | william anderson wittekind | acquired | - | - | 1,216,470 | - |
Jun 08, 2022 | sindlev rene | sold | - | - | -125,000 | - |
Jun 08, 2022 | sindlev rene | sold | - | - | -128,493 | - |
May 18, 2022 | sindlev rene | bought | 1,027,940 | 8.00 | 128,493 | - |
May 18, 2022 | gumrukcu serhat | sold | -2,027,940 | 8.00 | -253,493 | - |
May 18, 2022 | sindlev rene | bought | 1,000,000 | 8.00 | 125,000 | - |
Apr 15, 2022 | weird science llc | sold | - | - | -4,961,360 | - |
Which funds bought or sold ENOB recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 135 | 174,832 | 354,673 | -% |
May 16, 2024 | Tidal Investments LLC | new | - | 97,976 | 97,976 | -% |
May 15, 2024 | Schonfeld Strategic Advisors LLC | sold off | -100 | -42,478 | - | -% |
May 15, 2024 | Man Group plc | new | - | 285,927 | 285,927 | -% |
May 15, 2024 | Cubist Systematic Strategies, LLC | new | - | 52,984 | 52,984 | -% |
May 15, 2024 | BOOTHBAY FUND MANAGEMENT, LLC | sold off | -100 | -64,668 | - | -% |
May 15, 2024 | Brevan Howard Capital Management LP | new | - | 86,528 | 86,528 | -% |
May 15, 2024 | 683 Capital Management, LLC | sold off | -100 | -233,648 | - | -% |
May 15, 2024 | Laurion Capital Management LP | unchanged | - | -31,971 | 162,933 | -% |
May 15, 2024 | MARSHALL WACE, LLP | new | - | 90,792 | 90,792 | -% |
Unveiling Enochian Biosciences, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Enochian Biosciences, Inc. News
Income Statement (Quarterly) | |||||||||
Description | (%) Q/Q | 2016Q2 | 2016Q1 | 2015Q4 | 2013Q4 | 2013Q3 | 2013Q2 | 2013Q1 | 2012Q4 |
Revenue | - | 244 | - | 42,525 | 285 | 925 | - | 31,558 | - |
Gross Profit | - | 213 | - | 37,281 | -40,528 | -15,273 | -36,928 | 16,198 | - |
Income Taxes | 1276.7% | 397,824 | -33,808 | -340,103 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 265.9% | 212 | 58.00 | 58.00 | 58.00 | 79.00 | 80.00 | 83.00 | 85.00 | 180 | 183 | 184 | 190 | 174 | 173 | 175 | 178 | 181 | 178 | 181 | 180 | 178 |
Current Assets | -49.2% | 1.00 | 2.00 | 2.00 | 3.00 | 4.00 | 5.00 | 8.00 | 10.00 | 12.00 | 15.00 | 15.00 | 21.00 | 5.00 | 4.00 | 6.00 | 9.00 | 11.00 | 9.00 | 11.00 | 12.00 | 11.00 |
Cash Equivalents | 28.2% | 0.00 | 0.00 | 1.00 | 2.00 | 3.00 | 4.00 | 8.00 | 9.00 | 11.00 | 14.00 | 15.00 | 21.00 | 5.00 | 3.00 | 6.00 | 9.00 | 11.00 | 9.00 | 11.00 | 12.00 | 10.00 |
Net PPE | -1.6% | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Goodwill | 1310.5% | 164 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
Liabilities | 202.9% | 44.00 | 14.00 | 11.00 | 12.00 | 13.00 | 13.00 | 13.00 | 12.00 | 19.00 | 18.00 | - | 15.00 | 11.00 | 11.00 | 11.00 | 12.00 | 10.00 | 7.00 | 8.00 | 7.00 | 25.00 |
Current Liabilities | 51.7% | 21.00 | 14.00 | 10.00 | 11.00 | 12.00 | 11.00 | 7.00 | 6.00 | 8.00 | 6.00 | 1.00 | 2.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 |
Shareholder's Equity | 286.7% | 169 | 44.00 | 47.00 | 47.00 | 66.00 | 67.00 | 70.00 | 73.00 | 161 | 166 | 167 | 175 | 162 | 162 | 164 | 166 | 170 | 171 | 172 | 173 | 153 |
Retained Earnings | -6.6% | -274 | -257 | -253 | -244 | -220 | -216 | -212 | -204 | -114 | -107 | -101 | -90.91 | -73.55 | -69.52 | -66.58 | -64.19 | -60.09 | -58.58 | -56.86 | -52.77 | -53.94 |
Additional Paid-In Capital | 46.8% | 442 | 301 | 300 | 291 | 287 | 283 | 282 | 277 | 275 | 274 | 268 | 266 | 236 | 231 | 231 | 230 | 230 | 230 | 229 | 226 | 206 |
Accumulated Depreciation | - | 1.00 | - | - | 0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 119.4% | 147 | 67.00 | 66.00 | 64.00 | 58.00 | 56.00 | 55.00 | 53.00 | 53.00 | 53.00 | 52.00 | 52.00 | 48.00 | 47.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 45.00 | - | - | - | 243 | - | - | - | 83.00 | - | - | - | 69.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 16.3% | -2,633 | -3,146 | -2,777 | -2,261 | -3,307 | -3,551 | -2,653 | -3,050 | -2,784 | -4,620 | -5,276 | -13,028 | -2,330 | -2,496 | -2,755 | -2,245 | -3,838 | -2,575 | -1,800 | -2,218 | -2,737 |
Share Based Compensation | 86.3% | 1,862 | 999 | 984 | 721 | 968 | 820 | 1,026 | -110 | 578 | 2,043 | 2,728 | 186 | 352 | 359 | 326 | -11.25 | -28.09 | 690 | 234 | 162 | 97.00 |
Cashflow From Investing | -59.8% | -91.60 | -57.33 | -1,057 | -6.14 | - | - | - | - | - | - | -5.16 | -38.17 | - | -10.72 | - | -10.45 | -41.69 | -63.70 | -68.62 | 17.00 | -92.63 |
Cashflow From Financing | -7.2% | 2,641 | 2,847 | 2,563 | 1,248 | 2,109 | -300 | 1,458 | 1,070 | 230 | 2,951 | - | 29,203 | 3,439 | -40.41 | - | - | 6,200 | - | 1,000 | 4,320 | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Operating Expenses | ||||
General and administrative | $ 7,652,379 | $ 3,796,057 | $ 19,558,981 | $ 12,365,960 |
Research and development | 1,087,156 | 239,137 | 2,274,321 | 3,170,471 |
Intangible asset impairment (Note 5) | 8,421,000 | 0 | 8,421,000 | 0 |
Depreciation and amortization | 30,305 | 28,242 | 90,727 | 85,487 |
Total Operating Expenses | 17,190,840 | 4,063,436 | 30,345,029 | 15,621,918 |
LOSS FROM OPERATIONS | (17,190,840) | (4,063,436) | (30,345,029) | (15,621,918) |
Other Income (Expense) | ||||
Change in fair value of contingent consideration (Note 3) | 486,500 | 0 | 486,500 | 0 |
Loss on extinguishment of debt | 0 | 0 | (120,018) | 0 |
Loss on extinguishment of contingent consideration liability | 0 | 0 | 0 | (419,182) |
Interest expense | (303,802) | (122,289) | (758,057) | (310,766) |
Interest and other income (expense) | (16,272) | (142,571) | 8,041 | (133,938) |
Total Other Income (Expense) | 166,426 | (264,860) | (383,534) | (863,886) |
NET LOSS | $ (17,024,414) | $ (4,328,296) | $ (30,728,563) | $ (16,485,804) |
BASIC LOSS PER SHARE | $ (0.16) | $ (0.08) | $ (0.39) | $ (0.30) |
DILUTED LOSS PER SHARE | $ (0.16) | $ (0.08) | $ (0.39) | $ (0.30) |
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - BASIC | 107,480,475 | 55,974,605 | 79,168,663 | 55,524,511 |
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - DILUTED | 107,480,475 | 55,974,605 | 79,168,663 | 55,524,511 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Mar. 31, 2024 | Jun. 30, 2023 |
---|---|---|
CURRENT ASSETS: | ||
Cash | $ 312,697 | $ 1,874,480 |
Prepaids and other assets | 907,218 | 690,925 |
Total Current Assets | 1,219,915 | 2,565,405 |
Property and equipment, net | 488,915 | 508,989 |
OTHER ASSETS: | ||
Definite life intangible assets, net | 31,042 | 39,676 |
Indefinite life intangible assets | 44,945,255 | 42,611,000 |
Goodwill | 164,186,852 | 11,640,000 |
Deposits and other assets | 21,742 | 21,741 |
Operating lease right-of-use assets | 1,385,619 | 913,985 |
Total Other Assets | 210,570,510 | 55,226,402 |
TOTAL ASSETS | 212,279,340 | 58,300,796 |
CURRENT LIABILITIES: | ||
Accounts payable – trade | 7,990,631 | 5,296,823 |
Accrued expenses | 3,754,976 | 723,173 |
Other current liabilities | 519,427 | 184,733 |
Contingent consideration liability, current (Note 3) | 1,006,438 | 0 |
Current portion of operating lease liabilities | 483,226 | 193,422 |
Notes payable, net | 3,418,621 | 4,624,947 |
Convertible notes payable | 3,700,694 | 0 |
Total Current Liabilities | 20,874,013 | 11,023,098 |
NON-CURRENT LIABILITIES: | ||
Operating lease liabilities, net of current portion | 970,353 | 775,587 |
Contingent consideration liability, noncurrent (Note 3) | 19,064,562 | 0 |
Deferred tax liability | 2,774,856 | 0 |
Total Non-Current Liabilities | 22,809,771 | 775,587 |
Total Liabilities | 43,683,784 | 11,798,685 |
Commitments and Contingencies (Note 9) | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; zero shares issued and outstanding at March 31, 2024 and June 30, 2023 | 0 | 0 |
Common Stock, par value $0.0001, 350,000,000 shares authorized, 147,488,598 shares issued and outstanding at March 31, 2024, and 63,698,144 shares issued and outstanding at June 30, 2023 | 14,750 | 6,371 |
Additional paid-in capital | 442,304,652 | 290,554,875 |
Accumulated deficit | (274,757,816) | (244,029,253) |
Accumulated other comprehensive income (loss) | 1,033,970 | (29,882) |
Total Stockholders’ Equity | 168,595,556 | 46,502,111 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 212,279,340 | $ 58,300,796 |